Related Experiment Video

Updated: Nov 7, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.5K

DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells

Brianna Chen1, Dylan McCuaig-Walton1, Sean Tan1

  • 1Charles Perkins Centre and School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

International Journal of Molecular Sciences
|April 30, 2021
PubMed

Insights

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is vital for glioblastoma stem cell (GSC) differentiation. Inhibiting DYRK1A maintains GSC self-renewal by deactivating CDK5, thus preventing SOX2 gene expression and GSC differentiation.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology
  • Molecular Mechanisms of Cancer

Background:

  • Glioblastoma (GBM) exhibits significant cellular heterogeneity, with glioblastoma stem cells (GSCs) driving tumor growth and therapeutic resistance.
  • Understanding GSC stemness and differentiation is crucial for developing effective GBM treatments.
  • The role of Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) in cancer stem cell differentiation remains largely unexplored.

Purpose of the Study:

  • To investigate the role of DYRK1A in regulating the differentiation of glioblastoma stem cells.
  • To elucidate the molecular mechanisms by which DYRK1A controls GSC stemness and differentiation potential.

Main Methods:

  • Utilized glioblastoma stem cell models.
  • Investigated the kinase activity of DYRK1A and its downstream targets.
  • Assessed gene expression changes, specifically focusing on SOX2.
  • Examined the interaction and regulatory effects between DYRK1A and CDK5.

Main Results:

  • DYRK1A kinase activity is essential for the differentiation commitment of GSCs.
  • DYRK1A inhibition preserves the self-renewing GSC population by blocking differentiation signals.
  • DYRK1A deactivates CDK5, an oncogenic kinase, leading to reduced SOX2 expression.
  • This DYRK1A-CDK5-SOX2 pathway promotes GSC differentiation and limits stemness.

Conclusions:

  • DYRK1A plays a critical role in controlling glioblastoma stem cell differentiation.
  • The novel DYRK1A-CDK5-SOX2 signaling pathway offers new insights into GSC maintenance mechanisms.
  • Targeting DYRK1A may represent a therapeutic strategy to overcome GSC-mediated resistance in glioblastoma.
Keywords:
CDK5DYRK1ASOX2bone morphogenetic protein 4 (BMP4)cancer stem cellsglioblastoma

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.5K
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K